Cargando…
Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis–Manifested Severe Disease
Background: Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed. The real role of corticosteroid use in COVID-19 has long been of interest and is disputable. Methods: We aimed to quantitatively reevaluate the efficacy of corticosteroids on COVID-19. Databases were search...
Autores principales: | Cheng, Bin, Ma, Jinxiu, Yang, Yani, Shao, Tingting, Zhao, Binghao, Zeng, Linxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187793/ https://www.ncbi.nlm.nih.gov/pubmed/34122093 http://dx.doi.org/10.3389/fphar.2021.670170 |
Ejemplares similares
-
Safety of topical corticosteroids in atopic eczema: an umbrella review
por: Axon, Emma, et al.
Publicado: (2021) -
Neurological manifestations of COVID-19 infection: an umbrella review
por: Shams Vahdati, Samad, et al.
Publicado: (2021) -
Asthma, biologics, corticosteroids, and coronavirus disease 2019
por: Akenroye, Ayobami T., et al.
Publicado: (2020) -
Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study
por: Hong, Daqing, et al.
Publicado: (2020) -
An umbrella review of Lianhua Qingwen combined with Western medicine for the treatment of coronavirus disease 2019
por: Yang, Kelu, et al.
Publicado: (2022)